# Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

> **NCT06114628** · PHASE2 · RECRUITING · sponsor: **University College, London** · enrollment: 2500 (estimated)

## Conditions studied

- Pulmonary Tuberculosis

## Interventions

- **DRUG:** Ganfeborole
- **DRUG:** BTZ-043
- **DRUG:** Bedaquiline (B)
- **DRUG:** Delamanid (D)
- **DRUG:** Pretomanid (Pa)
- **DRUG:** Moxifloxacin (M)
- **DRUG:** Linezolid (L)
- **DRUG:** Pyrazinamide (Z)
- **DRUG:** Rifampicin (R)
- **DRUG:** Isoniazid (H)
- **DRUG:** Ethambutol (E)
- **DRUG:** Delpazolid (DZD)
- **DRUG:** Quabodepistat (Q)

## Key facts

- **NCT ID:** NCT06114628
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-09
- **Primary completion:** 2027-02-24
- **Final completion:** 2027-08-11
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2025-10-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06114628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06114628, "Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06114628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*